Drug lookup
Drug reference

pretomanid

Bicyclic nitroimidazole · Antituberculosis

Bicyclic nitroimidazoleAntituberculosis
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
not curated
Top interactionssee all 12
  • Strong Or Moderate Cyp3a InducersSevereTextbookG&G 14e · p1277
  • ApalutamideSevereDatabaseDDInter
  • BosentanSevereDatabaseDDInter
  • CarbamazepineSevereDatabaseDDInter

Mechanism

Pretomanid inhibits M. tuberculosis mycolic acid and protein synthesis under aerobic conditions. It is a prodrug requiring bacterial activation via a nitroreduction step involving FGD1 (NADP-dependent G6PD) and cofactor F420. In nonreplicating persistent bacilli, it generates reactive nitrogen species such as nitric oxide via its des-nitro metabolite, augmenting the kill of intracellular NRPB, and causes ATP depletion by poisoning the respiratory complex.

Indications

extensively drug-resistant tuberculosis (in combination with bedaquiline and linezolid)

Dosing

Adult
200 mg/day

Pharmacokinetics

Metabolism
Approximately 20% by CYP3A

Side effects

Serious
  • hepatotoxicity (under investigation)
  • effects on human male fertility (under investigation)

Drug interactions

Strong Or Moderate Cyp3a Inducers
Severe
Textbook

Reduced pretomanid exposures.

Avoid coadministration with strong or moderate CYP3A inducers.

Source: G&G 14e · p1277

Apalutamide
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Bosentan
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Carbamazepine
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Cenobamate
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Dabrafenib
Severe
Database

Clinical effect not specified

Source: DDInter

Dexamethasone
Severe
Database

Clinical effect not specified

Source: DDInter

Efavirenz
Severe
Database

Clinical effect not specified

Source: DDInter

Enzalutamide
Severe
Database

Clinical effect not specified

Source: DDInter

Eslicarbazepine
Severe
Database

Drug interaction classified as: metabolism

Source: DDInter

Etravirine
Severe
Database

Clinical effect not specified

Source: DDInter

Fosphenytoin
Severe
Database

Clinical effect not specified

Source: DDInter

Related guidelines

Ask House about pretomanid

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e, Harrison 22e·Verified: 2026-05-10 · House clinical team